Free Trial

Candel Therapeutics (CADL) Institutional Ownership

Candel Therapeutics logo
$4.82 -0.43 (-8.19%)
Closing price 04:00 PM Eastern
Extended Trading
$4.84 +0.01 (+0.31%)
As of 05:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Candel Therapeutics (NASDAQ:CADL)

Current
Institutional Ownership
Percentage
13.93%
Number of
Institutional Buyers
(last 12 months)
35
Total
Institutional Inflows
(last 12 months)
$71.95M
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$3.22M
Get CADL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Candel Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

CADL Institutional Buying and Selling by Quarter

Remove Ads

Candel Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2025Squarepoint Ops LLC19,311$168K0.0%+86.6%0.059%
2/17/2025Nuveen Asset Management LLC68,226$592K0.0%+3.0%0.210%
2/17/2025Maven Securities LTD51,731$449K0.0%N/A0.159%
2/17/2025Millennium Management LLC31,626$275K0.0%+130.6%0.097%
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.12,165$106K0.0%+12.4%0.037%
2/17/2025Deutsche Bank AG31,522$274K0.0%+5,814.1%0.097%
2/17/2025Bridgeway Capital Management LLC77,195$670K0.0%-4.2%0.238%
2/17/2025Braidwell LP1,600,000$13.89M0.4%N/A4.926%
2/17/2025Baker BROS. Advisors LP2,981,983$25.88M0.3%N/A9.181%
2/17/2025Bank of America Corp DE66,811$580K0.0%+205.6%0.206%
2/17/2025BNP Paribas Financial Markets3,434$30K0.0%N/A0.011%
2/17/2025Acorn Capital Advisors LLC1,939,644$16.84M9.2%N/A5.972%
2/14/2025Northern Trust Corp165,021$1.43M0.0%+3.9%0.508%
2/14/2025Oxford Asset Management LLP12,003$104K0.1%N/A0.037%
2/14/2025Birchview Capital LP60,000$521K0.4%N/A0.185%
2/14/2025Heights Capital Management Inc.30,000$260K0.1%N/A0.092%
2/14/2025MetLife Investment Management LLC13,773$120K0.0%+9.7%0.042%
2/13/2025Portolan Capital Management LLC753,745$6.54M0.4%N/A2.321%
2/13/2025Barclays PLC34,317$297K0.0%+19.6%0.106%
2/13/2025Russell Investments Group Ltd.3,753$33K0.0%+75.1%0.012%
2/13/2025Wells Fargo & Company MN10,122$88K0.0%+63.6%0.031%
2/12/2025Geode Capital Management LLC455,424$3.95M0.0%+1.4%1.402%
2/12/2025JPMorgan Chase & Co.10,426$90K0.0%+15.2%0.032%
2/11/2025LPL Financial LLC10,703$93K0.0%N/A0.033%
2/11/2025Halter Ferguson Financial Inc.681,334$5.91M2.4%+123.7%2.098%
2/10/2025Commonwealth Equity Services LLC41,098$357K0.0%N/A0.127%
2/6/2025Charles Schwab Investment Management Inc.52,190$453K0.0%+11.6%0.161%
2/5/2025Oppenheimer & Co. Inc.37,915$329K0.0%N/A0.117%
1/30/2025Rhumbline Advisers26,272$228K0.0%+17.0%0.081%
1/30/2025Vontobel Holding Ltd.19,000$165K0.0%-13.6%0.058%
1/15/2025HB Wealth Management LLC87,300$696K0.0%+54.1%0.269%
12/26/2024JPMorgan Chase & Co.9,051$63K0.0%-53.2%0.028%
11/19/2024Barclays PLC28,688$199K0.0%+327.1%0.088%
11/16/2024Geode Capital Management LLC448,997$3.11M0.0%+12.8%1.399%
11/15/2024Barclays PLC28,688$199K0.0%+327.1%0.089%
11/15/2024MML Investors Services LLC22,313$155K0.0%-69.6%0.070%
11/15/2024State Street Corp492,005$3.41M0.0%+4.1%1.534%
11/15/2024Atom Investors LP14,873$103K0.0%N/A0.046%
11/14/2024MetLife Investment Management LLC12,558$87K0.0%N/A0.039%
11/13/2024FMR LLC6,573$46K0.0%N/A0.020%
Trump’s Secret Weapon (Ad)

Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.

Get Your FREE Presidential Transition Guide Today
9/16/2024Point72 DIFC Ltd4,927$31K0.0%N/A0.017%
9/16/2024Cubist Systematic Strategies LLC26,121$162K0.0%N/A0.088%
8/14/2024Cubist Systematic Strategies LLC26,121$162K0.0%N/A0.088%
8/14/2024Point72 DIFC Ltd4,927$31K0.0%N/A0.017%
8/13/2024Sands Capital Ventures LLC405,837$2.52M0.8%-50.0%1.364%
8/9/2024Renaissance Technologies LLC20,600$128K0.0%-63.8%0.069%
8/1/2024Rhumbline Advisers22,985$143K0.0%N/A0.077%
7/26/2024Bank of New York Mellon Corp54,449$338K0.0%N/A0.183%
1/29/2024Baystate Wealth Management LLC76,910$113K0.0%-21.0%0.266%
5/10/2023Resources Investment Advisors LLC.25,428$34K0.0%N/A0.088%
4/25/2023Baystate Wealth Management LLC105,854$143K0.0%N/A0.366%
11/14/2022Point72 Asset Management L.P.403,131$1.27M0.0%-45.7%1.395%
5/6/2022Empirical Asset Management LLC12,000$61K0.1%N/A0.042%
4/26/2022Kestra Advisory Services LLC12,500$64K0.0%N/A0.044%
2/15/2022Northpond Ventures LLC1,935,215$15.13M5.3%N/A6.745%
2/15/2022683 Capital Management LLC40,929$320K0.0%N/A0.143%
11/15/2021Caas Capital Management LP50,000$542K0.0%N/A0.174%
11/15/2021Franklin Resources Inc.1,125,000$12.20M0.0%N/A3.921%
11/9/2021BlackRock Inc.22,326$242K0.0%N/A0.078%
(Data available from 1/1/2016 forward)

Remove Ads

CADL Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CADL shares?

During the previous two years, 42 institutional investors and hedge funds held shares of Candel Therapeutics. The most heavily invested institutionals were Baker BROS. Advisors LP ($25.88M), Acorn Capital Advisors LLC ($16.84M), Braidwell LP ($13.89M), Portolan Capital Management LLC ($6.54M), Halter Ferguson Financial Inc. ($5.91M), Geode Capital Management LLC ($3.95M), and State Street Corp ($3.41M).Learn more on CADL's institutional investors.

What percentage of Candel Therapeutics stock is owned by institutional investors?

13.93% of Candel Therapeutics stock is owned by institutional investors. Learn more on CADL's institutional investor holdings.

Which institutional investors have been buying Candel Therapeutics stock?

Of the 37 institutional investors that purchased Candel Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Baker BROS. Advisors LP ($2.98M), Acorn Capital Advisors LLC ($1.94M), Braidwell LP ($1.60M), Portolan Capital Management LLC ($753.75K), Halter Ferguson Financial Inc. ($376.80K), Baystate Wealth Management LLC ($105.85K), and Birchview Capital LP ($60K).

How much institutional buying is happening at Candel Therapeutics?

Institutional investors have bought a total of 8,490,606 shares in the last 24 months. This purchase volume represents approximately $72.13M in transactions.

Which Candel Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Candel Therapeutics stock in the last 24 months: Sands Capital Ventures LLC ($405.90K), MML Investors Services LLC ($51.06K), Renaissance Technologies LLC ($36.31K), Baystate Wealth Management LLC ($20.40K), JPMorgan Chase & Co. ($10.31K), Bridgeway Capital Management LLC ($3.40K), and Vontobel Holding Ltd. ($3K).

How much institutional selling is happening at Candel Therapeutics?

Institutional investors have sold a total of 530,375 shares in the last 24 months. This volume of shares sold represents approximately $3.25M in transactions.



This page (NASDAQ:CADL) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners